US Patent Issued to CRYSTAL PHARMACEUTICAL (SUZHOU) on April 7 for "Crystal form of Resmetirom, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,254, issued on April 7, was assigned to CRYSTAL PHARMACEUTICAL (SUZHOU) Co. LTD. (Suzhou, China).

"Crystal form of Resmetirom, preparation method therefor, and use thereof" was invented by Minhua Chen (Suzhou, China) and Chunxiang Huang (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a new crystal form of Resmetirom (referred to as "Compound I") and a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in preparing a THR-Beta selective agonist drug and a drug for treating NASH and HeFH. Compared with the prior art, the provided crystal for...